Understand the source comparison
P21 Work for Hippocampal Research: Comparison Table
LTP induction studies Enhances CREB phosphorylation, lowers stimulation threshold for synaptic strengthening 24–72 hours for molecular changes; 7–14 days for behavioral effects Increased dendritic spine density, elevated BDNF mRNA, enhanced field EPSP amplitud
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- LTP induction studies
- Enhances CREB phosphorylation, lowers stimulation threshold for synaptic strengthening
- 24–72 hours for molecular changes; 7–14 days for behavioral effects
- Increased dendritic spine density, elevated BDNF mRNA, enhanced field EPSP amplitude
- Ideal for electrophysiology labs studying synaptic plasticity mechanisms. Effects are dose-dependent and reproducible
- Neurogenesis quantification
- Promotes BDNF-dependent survival and integration of newborn neurons in dentate gyrus
- 14–21 days (minimum time for new neurons to mature and functionally integrate)
- BrdU+ cells in subgranular zone, doublecortin staining, NeuN co-labeling
- Best suited for long-term studies. Neurogenesis is a slow process and requires sustained P21 exposure for measurable effects
- Cognitive rescue in injury models
- Activates neuroprotective pathways, reduces apoptosis, supports synaptic repair post-insult
- 7–10 days post-injury for functional recovery; molecular changes within 48 hours
- Reduced caspase-3 activation, improved maze performance, maintained CA1 cell density
- Strong evidence base. Multiple studies confirm functional recovery in ischemia and excitotoxicity models; replicates well
- Healthy baseline enhancement
- Minimal effect in absence of pre-existing deficit
- No significant timeline. Effects negligible in young, healthy models
- No consistent biomarker changes observed
- Not recommended. P21 works by compensating for impaired plasticity, not by enhancing already-optimal function